NASDAQ:CTMX
CytomX Therapeutics Stock News
$4.43
-0.0700 (-1.56%)
At Close: May 03, 2024
Los Angeles, California--(Newsfile Corp. - July 20, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CytomX Therapeuti
LAWSUITS FILED AGAINST CTMX, PPC and BKD - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
12:50pm, Monday, 20'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 20, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who
SHAREHOLDER ALERT: CTMX PPC JCOM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
11:30am, Monday, 20'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 20, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies.
SHAREHOLDER ALERT: CTMX PPC WRCDF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
10:20am, Monday, 20'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 20, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies.
LOS ANGELES, CA / ACCESSWIRE / July 20, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc.
LOS ANGELES, CA / ACCESSWIRE / July 18, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc.
NEW YORK, NY / ACCESSWIRE / July 18, 2020 / Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CytomX Therapeutics, Inc.
New York, New York--(Newsfile Corp. - July 17, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CytomX Therapeutics, Inc. ("CytomX" or the "Company") (NASDA
NEW YORK, July 17, 2020 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against CytomX.
Los Angeles, California--(Newsfile Corp. - July 17, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CytomX Therapeuti
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CTMX, ENDP and CSPR
03:50pm, Friday, 17'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 17, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies.
NEW YORK, July 17, 2020 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CytomX Therapeutics, Inc. (NASDAQ: CTMX) between May 17,.
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CTMX, ENDP and CEMI
07:45pm, Thursday, 16'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 16, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies.
LOS ANGELES, CA / ACCESSWIRE / July 16, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc. ("C
